INCB081776

DRUG2 trials

Sponsors

Incyte Corporation, University of Wisconsin, Madison

Conditions

Advanced Solid TumorsHead and Neck Squamous Cell Carcinoma

Early Phase 1

Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

RecruitingNCT06308913

University of Wisconsin, MadisonHead and Neck Squamous Cell Carcinoma

Start: 2024-09-18End: 2027-08-31Target: 12Updated: 2025-07-15

Phase 1

A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

TerminatedNCT03522142

Incyte CorporationAdvanced Solid Tumors

Start: 2018-08-27End: 2025-09-10Updated: 2025-10-09